Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy
Document Type
Article
Publication Date
2018
Recommended Citation
Shubrook, J. H. (2018). Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy. Journal of Family Practice, 67 (Suppl. 8), S49-S54. Retrieved from https://touroscholar.touro.edu/tuccom_pubs/120
Publisher's Statement
The original material can be found here: https://perma.cc/T49A-VZDN
